Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema

Journal of Medical Genetics

Volumn 40, Issue 9, 2003, Pages 697-703

  Evans, Alison L ^a   Bell, R ^a   Brice, G ^a   Comeglio, P ^a   Lipede, C ^a   Jeffery, S ^a   Mortimer, P ^a   Sarfarazi, M ^b   Child, A H ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR 3;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CELLULITIS; CHROMOSOME 5Q; CLEFT PALATE; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC TRANSDUCTION; HAPLOTYPE; HUMAN; HYPERKERATOSIS; LYMPHEDEMA; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PTOSIS; SKINFOLD;

EID: 0042329924     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.40.9.697     Document Type: Article

References (22)

1. Mortimer PS. Managing lymphedema. Clin Dermatol 1995;13:499-505.
2. Dale RF. The inheritance of primary lymphedema. J Med Genet 1985;22:274-8.
3. Evans AL, Brice G, Sotirova V, et al. Mapping of primary congenital lymphedema to the 5q35.3 region. Am J Hum Genet 1999;64:547-55.
4. Greenlee R, Hoyme H, Witte M, et al. Developmental disorders of the lymphatic system. Lymphology 1993;26:156-68.
5. Mangion J, Rahman N, Mansour S, et al. A gene for lymphedema-distichiasis maps to 16q24.3. Am J Hum Genet 1999;65:427-32.
6. Bell R, Brice G, Child AH, et al. Reduction of the genetic interval for lymphoedema-distichiasis to below 2 Mb. J Med Genet 2000;37:725-6.
7. Fang J, Dagenais SL, Erickson RP, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000;67:1382-8.
8. Bell R, Brice G, Child AH, et al. Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum Genet 2001;108:546-51.
9. Finegold DN, Kimak MA, Lawrence EC, et al. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 2001;10:1185-9.
10. Brice G, Mansour S, Bell R, et al. Analysis of the phenotypic abnormalities in Lymphoedema Distichiasis Syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 2002;39:478-83.
11. Ferrell RE, Levinson KL, Esman JH, et al. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet 1998;7:2073-8.
12. Irrthum A, Karkkainen MJ, Devriendt K, et al. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 2000;67:295-301.
13. Karkkainen MJ, Ferrell RE, Lawrence EC, et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 2000;25:153-9.
14. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothetium during development. Proc Natl Acad Sci USA 1995;92:3566-70.
15. Dumont DJ, Jussila L, Taipale J, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptar-3. Science 1998;282:946-9.
16. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276:1423-5.
17. Stemmer R. Ein Klinisches Zeichen zur Fruhund Differential Diagnose des Lymphodems. VASA 1976;5:261-2.
18. Moore D. Preparation of genomic DNA. In: Ausubel FM, Brent R, Kingston RE, eds. Current protocols in molecular biology. New York, 1994:2.1.1-8.
19. Iljin K, Karkkainen MJ, Lawrence EC, et al. VEGFR-3 gene structure, regulatory region, and sequence polymorphisms. FASEB J 2001;15:1028-36.
20. Milroy WF. An undescribed variety of hereditary oedema. NY Med J 1892;56:503.
21. Hanks SK, Hunter T. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 1995;9:576-96.
22. Hubbard SR. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 1997;16:5572-81.